Cargando…
Recent developments in PD-1/PD-L1 blockade research for gastroesophageal malignancies
Gastroesophageal cancers (GECs) comprise malignancies in the stomach, esophagus, and gastroesophageal junction. Despite ongoing improvements in chemoradiotherapy, the clinical outcomes of GEC have not significantly improved over the years, and treatment remains challenging. Immune checkpoint inhibit...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731511/ https://www.ncbi.nlm.nih.gov/pubmed/36505480 http://dx.doi.org/10.3389/fimmu.2022.1043517 |